(Q54574335)

1 June 2018

title

Opposite Changes in Serum Soluble CD8 in Patients at the Active Stages of Graves' and Hashimoto's Diseases (English)

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1089/THY.1997.7.743

21 November 2024

M. Watanabe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9349577

21 November 2024

N. Amino

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9349577

21 November 2024

K. Hochito

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9349577

21 November 2024

K. Watanabe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9349577

21 November 2024

K. Kuma

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9349577

21 November 2024

Y. Iwatani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9349577

21 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9349577

21 November 2024

publication date

1 October 1997

1 reference

1 June 2018

October 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9349577

full work available at URL

21 November 2024

https://www.liebertpub.com/doi/pdf/10.1089/thy.1997.7.743

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1089/THY.1997.7.743

21 November 2024

1 reference

1 June 2018

volume

1 reference

1 June 2018

issue

1 reference

1 June 2018

page(s)

743-747

1 reference

1 June 2018

Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins

cites work

1 reference

https://api.crossref.org/works/10.1089/THY.1997.7.743

Spontaneous release of the Leu-2 (T8) molecule from human T cells

21 November 2024

1 reference

https://api.crossref.org/works/10.1089/THY.1997.7.743

Immune activation in measles

21 November 2024

1 reference

https://api.crossref.org/works/10.1089/THY.1997.7.743

High serum levels of soluble CD8 in insulin-dependent diabetes

21 November 2024

1 reference

https://api.crossref.org/works/10.1089/THY.1997.7.743

Decreases in alpha beta T cell receptor negative T cells and CD8 cells, and an increase in CD4+ CD8+ cells in active Hashimoto's disease and subacute thyroiditis

21 November 2024

1 reference

https://api.crossref.org/works/10.1089/THY.1997.7.743

Serum soluble CD8 concentration is an indicator of disease activity in patients with Graves' disease

21 November 2024

1 reference

https://api.crossref.org/works/10.1089/THY.1997.7.743

CD8 is critically involved in lymphocyte activation by a T. brucei brucei-released molecule

21 November 2024

1 reference

https://api.crossref.org/works/10.1089/THY.1997.7.743

Studies on Suppressor Cell Function in Thyroid Diseases*

21 November 2024

1 reference

https://api.crossref.org/works/10.1089/THY.1997.7.743

Intrathyroidal lymphocyte subsets, including unusual CD4+ CD8+ cells and CD3loTCR alpha beta lo/-CD4-CD8- cells, in autoimmune thyroid disease

21 November 2024

1 reference

https://api.crossref.org/works/10.1089/THY.1997.7.743

Intrathyroidal T cell clones from patients with autoimmune thyroid disease

21 November 2024

1 reference

https://api.crossref.org/works/10.1089/THY.1997.7.743

21 November 2024

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018